Type 2 diabetes is one of the most common, costly, and disabling diseases in the world. Approximately one million patients in Michigan have type 2 diabetes and rates are up to 2x higher for Michiganders who are Black, Latino, or have a disability. At the same time, the implementation of guideline concordant diabetes care lags behind due to challenges with coverage, lack of resources, cost of medications, and lack of support and education. Primary care practices continue to combat staffing issues, lack of resources, and increasing administrative demands. Meanwhile coordination of care for diabetes is confounded by an increasingly-complex healthcare system.
The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work.

Mission

MCT2D strives to prevent type 2 diabetes and its complications by fostering a collaborative community of clinicians and patients to accelerate the equitable implementation of evidence-based diabetes care for all patients in Michigan.

Vision

A world where Type 2 Diabetes is no longer a progressive disease.

Quality Initiatives

Together, we work to accelerate the implementation of quality diabetes care, including three guiding initiatives

MORE ON QUALITY INITIATIVES

How MCT2D Supports Members

Meet the Program Directors

OUR TEAM

Read our Latest Annual Report

2023 Annual Report2022 Annual Report

PRESENTATIONS AND PUBLICATIONS

Go to Publications page

NEWSLETTERS

News from the MCT2D Team


MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org